CIK 0001683553 · Non-accelerated filer<br>Smaller reporting company
SPRUCE BIOSCIENCES, INC.
Sign in to watch- Ticker
- SPRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812154263
- Phone
- (415) 655-4168
- Business address
- 611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-11 | GREY MICHAEL G Executive Chairman | Returned to the company · Stock Option (Right to Buy) | −1,499 | 0 | ||
| 2025-12-11 | GREY MICHAEL G Executive Chairman | Grant or award · Stock Option (right to buy) | +133 | 133 | ||
| 2025-12-11 | GREY MICHAEL G Executive Chairman | Returned to the company · Stock Option (right to buy) | −133 | 0 | ||
| 2025-12-11 | GREY MICHAEL G Executive Chairman | Grant or award · Stock Option (Right to Buy) | +666 | 666 | ||
| 2025-12-11 | GREY MICHAEL G Executive Chairman | Returned to the company · Stock Option (Right to Buy) | −666 | 0 | ||
| 2025-12-11 | GREY MICHAEL G Executive Chairman | Grant or award · Stock Option (Right to Buy) | +400 | 400 | ||
| 2025-12-11 | GREY MICHAEL G Executive Chairman | Returned to the company · Stock Option (Right to Buy) | −400 | 0 | ||
| 2025-12-11 | SPIEGELMAN DANIEL K Director | Grant or award · Stock Option (Right to Buy) | +458 | 458 | ||
| 2025-12-11 | SPIEGELMAN DANIEL K Director | Returned to the company · Stock Option (Right to Buy) | −458 | 0 | ||
| 2025-12-11 | SPIEGELMAN DANIEL K Director | Grant or award · Stock Option (right to buy) | +88 | 88 | ||
| 2025-12-11 | SPIEGELMAN DANIEL K Director | Returned to the company · Stock Option (right to buy) | −88 | 0 | ||
| 2025-12-11 | SPIEGELMAN DANIEL K Director | Grant or award · Stock Option (Right to Buy) | +400 | 400 | ||
| 2025-12-11 | SPIEGELMAN DANIEL K Director | Returned to the company · Stock Option (Right to Buy) | −400 | 0 | ||
| 2025-12-11 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Option exercise | +4,950 | 15,192 | ||
| 2025-12-11 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −2,194 | $88.41 | $194K | 12,998 |
| 2025-12-11 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Grant or award · Restricted Stock Units | +19,800 | 19,800 | ||
| 2025-12-11 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −4,950 | 14,850 | ||
| 2025-12-11 | Gharib Samir M. PRESIDENT AND CFO | Option exercise | +1,900 | 8,296 | ||
| 2025-12-11 | Gharib Samir M. PRESIDENT AND CFO | Shares withheld for taxes | −680 | $88.41 | $60K | 7,616 |
| 2025-12-11 | Gharib Samir M. PRESIDENT AND CFO | Grant or award · Restricted Stock Units | +7,600 | 7,600 |
Page 4 of 12 · 231 trades